Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claire M Robinson

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
FEBS Letters|March 4, 2014
The multifaceted von Hippel-Lindau tumour suppressor proteinClaire M Robinson, Michael Ohh
Frontiers in Molecular Biosciences|February 5, 2024
ER exit in physiology and diseaseClaire M Robinson, Aislinn Duggan, Alison Forrester
Biochimica Et Biophysica Acta. Reviews on Cancer|October 4, 2022
Unfolded protein response at the cross roads of tumourigenesis, oxygen sensing and drug resistance in clear cell renal cell carcinomaYew Hwang Chee, Afshin Samali, Claire M Robinson
Epigenetics|August 17, 2012
Epigenetics within the matrix: a neo-regulator of fibrotic diseaseClaire M Robinson, Chris J Watson, John A Baugh
Nature Communications|August 24, 2018
HIF-2α-pVHL complex reveals broad genotype-phenotype correlations in HIF-2α-driven diseaseDaniel Tarade, Claire M Robinson, Jeffrey E Lee, et al.
Biochemical and Biophysical Research Communications|November 23, 2021
Side population analysis in clear cell renal cell carcinomaRichard Huang, Jalna Meens, Scott Yuzwa, et al.
Respiratory Research|September 4, 2012
Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotypeClaire M Robinson, Roisin Neary, Ashleigh Levendale, et al.
Cancers|January 15, 2021
An Emerging Role for the Unfolded Protein Response in Pancreatic CancerClaire M Robinson, Aaron Talty, Susan E Logue, et al.
Molecular Cancer Research : MCR|August 21, 2019
A Hypoxia-Inducible HIF1-GAL3ST1-Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell-Platelet BindingClaire M Robinson, Betty P K Poon, Yoshihito Kano, et al.
Cancer Research|June 27, 2020
<i>NRAS</i> Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS-MAPK Pathway in NeuroblastomaIvette Valencia-Sama, Yagnesh Ladumor, Lynn Kee, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
FEBS Letters|March 4, 2014
The multifaceted von Hippel-Lindau tumour suppressor proteinClaire M Robinson, Michael Ohh
Frontiers in Molecular Biosciences|February 5, 2024
ER exit in physiology and diseaseClaire M Robinson, Aislinn Duggan, Alison Forrester
Biochimica Et Biophysica Acta. Reviews on Cancer|October 4, 2022
Unfolded protein response at the cross roads of tumourigenesis, oxygen sensing and drug resistance in clear cell renal cell carcinomaYew Hwang Chee, Afshin Samali, Claire M Robinson
Epigenetics|August 17, 2012
Epigenetics within the matrix: a neo-regulator of fibrotic diseaseClaire M Robinson, Chris J Watson, John A Baugh
Nature Communications|August 24, 2018
HIF-2α-pVHL complex reveals broad genotype-phenotype correlations in HIF-2α-driven diseaseDaniel Tarade, Claire M Robinson, Jeffrey E Lee, et al.
Biochemical and Biophysical Research Communications|November 23, 2021
Side population analysis in clear cell renal cell carcinomaRichard Huang, Jalna Meens, Scott Yuzwa, et al.
Respiratory Research|September 4, 2012
Hypoxia-induced DNA hypermethylation in human pulmonary fibroblasts is associated with Thy-1 promoter methylation and the development of a pro-fibrotic phenotypeClaire M Robinson, Roisin Neary, Ashleigh Levendale, et al.
Cancers|January 15, 2021
An Emerging Role for the Unfolded Protein Response in Pancreatic CancerClaire M Robinson, Aaron Talty, Susan E Logue, et al.
Molecular Cancer Research : MCR|August 21, 2019
A Hypoxia-Inducible HIF1-GAL3ST1-Sulfatide Axis Enhances ccRCC Immune Evasion via Increased Tumor Cell-Platelet BindingClaire M Robinson, Betty P K Poon, Yoshihito Kano, et al.
Cancer Research|June 27, 2020
<i>NRAS</i> Status Determines Sensitivity to SHP2 Inhibitor Combination Therapies Targeting the RAS-MAPK Pathway in NeuroblastomaIvette Valencia-Sama, Yagnesh Ladumor, Lynn Kee, et al.
Pageof 2